Literature DB >> 16893075

Complement activation during sepsis in humans.

Heike Schreiber1, Daniel Rittirsch, Michael Flierl, Uwe Brueckner, Marion Schneider, Manfred Weiss, Florian Gebhard, Markus Huber-Lang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893075     DOI: 10.1007/0-387-34134-X_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?

Authors:  Michael A Flierl; Jennifer L Gaudiani; Allison L Sabel; Carlin S Long; Philip F Stahel; Philip S Mehler
Journal:  Ann Gen Psychiatry       Date:  2011-05-04       Impact factor: 3.455

2.  A new experimental polytrauma model in rats: molecular characterization of the early inflammatory response.

Authors:  Sebastian Weckbach; Mario Perl; Tim Heiland; Sonja Braumüller; Philip F Stahel; Michael A Flierl; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mediators Inflamm       Date:  2012-02-29       Impact factor: 4.711

Review 3.  Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards precision medicine?

Authors:  Thilo von Groote; Melanie Meersch-Dini
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

Review 4.  Biomarkers of sepsis.

Authors:  James D Faix
Journal:  Crit Rev Clin Lab Sci       Date:  2013 Jan-Feb       Impact factor: 6.250

5.  Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.

Authors:  William Bain; Huihua Li; Rick van der Geest; Sara R Moore; Tolani F Olonisakin; Brian Ahn; Erin Papke; Kaveh Moghbeli; Rebecca DeSensi; Sarah Rapport; Melissa Saul; Mei Hulver; Zeyu Xiong; Rama K Mallampalli; Prabir Ray; Alison Morris; Lina Ma; Yohei Doi; Yingze Zhang; Georgios D Kitsios; Hrishikesh S Kulkarni; Bryan J McVerry; Viviana P Ferreira; Mehdi Nouraie; Janet S Lee
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.